<DOC>
	<DOCNO>NCT01906749</DOCNO>
	<brief_summary>Multicenter , double blind , randomize trial ass effect low-dose colchicine ( 0.5mg/day ) overall mortality , new coronary syndrome , ischemic stroke 2 year acute coronary syndrome . The study hypothesis colchicine may reduce specify combined endpoint 16 % 7-8 % 2-years follow-up .</brief_summary>
	<brief_title>Colchicine Acute Coronary Syndromes</brief_title>
	<detailed_description>Multicenter , double-blind randomize trial evaluate efficacy low dose colchicine ( 0.5mg daily 2 year ) reduce incidence subsequent overall mortality , new acute coronary syndrome , ischemic stroke patient admit acute coronary syndrome .</detailed_description>
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Acute Coronary Syndrome</mesh_term>
	<mesh_term>Colchicine</mesh_term>
	<criteria>&gt; 18years Acute coronary syndrome ( unstable angina acute myocardial infarction ) Life expectancy &gt; 2 year Absence contraindication colchicine Colchicine treatment cause Severe liver disease Renal insufficiency creatinine &gt; 150mmol/l creatinine clearance &lt; 30ml/min/1.73m2 Known cancer Chronic inflammatory bowel disease treatment cyclosporine allergy hypersensitivity colchicine pregnancy lactate woman woman childbearing potential without valid contraception</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>90 Years</maximum_age>
	<verification_date>July 2013</verification_date>
	<keyword>Acute coronary syndrome</keyword>
	<keyword>Colchicine</keyword>
</DOC>